1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. IMMUNITYBIO INC
ImmunityBio Inc
XNAS: IBRX
7.83 -0.55 (-6.56%)
7.4M
XNAS Volume

XNAS 07 May, 2026 11:36 AM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for ImmunityBio Inc is on 12 May 2026 for the purpose of ImmunityBio Inc First Quarter Earnings Results for 2026 See details

ImmunityBio Inc - IBRX - stock price prediction, stock price target, analyst ratings from 4 analysts

ImmunityBio Inc has a share price target of US$ 16, revenue growth forecast of 93.1%, and profit growth estimate of 24.1% for FY26, based on top 4 analyst calls.